Deutsche Bank Ag\ Iveric Bio, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$26.24 - $39.63 $50.1 Million - $75.7 Million	1,910,414 Added 149.03%	3,192,342 $126 Million
Q1 2023 May 15, 2023	SELL	$18.67 - $24.56 $21.4 Million - $28.2 Million	-1,148,521 Reduced 47.26%	1,281,928 $31.2 Million
Q4 2022 Feb 13, 2023	BUY	$17.24 - $23.95 $234,084 - $325,193	13,578 Added 0.56%	2,430,449 $52 Million
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $41,839 - $82,744	-4,451 Reduced 0.18%	2,416,871 $43.4 Million
Q2 2022 Aug 11, 2022	BUY	$9.12 - $18.9 $21.1 Million - $43.8 Million	2,317,598 Added 2234.39%	2,421,322 $23.3 Million
Q1 2022 May 13, 2022	BUY	$12.15 - $16.83 $394,656 - $546,672	32,482 Added 45.59%	103,724 $1.75 Million
Q4 2021 Feb 11, 2022	SELL	$13.83 - $18.78 $6.58 Million - $8.94 Million	-475,961 Reduced 86.98%	71,242 $1.19 Million
Q3 2021 Nov 04, 2021	BUY	$7.07 - $17.5 $696,684 - $1.72 Million	98,541 Added 21.96%	547,203 $8.89 Million
Q2 2021 Aug 11, 2021	BUY	$5.69 - $7.17 $13,121 - $16,534	2,306 Added 0.52%	448,662 $2.83 Million
Q1 2021 May 13, 2021	SELL	$5.08 - $6.89 $1.02 Million - $1.39 Million	-201,742 Reduced 31.13%	446,356 $2.76 Million
Q4 2020 Feb 16, 2021	BUY	$5.65 - $7.66 $3.16 Million - $4.28 Million	558,853 Added 626.2%	648,098 $4.48 Million
Q3 2020 Nov 12, 2020	BUY	$4.01 - $6.29 $274,612 - $430,751	68,482 Added 329.83%	89,245 $503,000
Q2 2020 Aug 13, 2020	SELL	$3.06 - $6.6 $2.45 Million - $5.29 Million	-801,287 Reduced 97.47%	20,763 $106,000
Q1 2020 May 14, 2020	BUY	$2.83 - $8.44 $2.33 Million - $6.94 Million	822,050 New	822,050 $2.83 Million
Q4 2019 Feb 14, 2020	SELL	$0.93 - $8.58 $8,595 - $79,304	-9,243 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.09 - $1.29 $142,906 - $169,128	-131,107 Reduced 93.41%	9,243 $10,000
Q2 2019 Aug 14, 2019	BUY	$1.21 - $1.48 $169,823 - $207,718	140,350 New	140,350 $182,000

Others Institutions Holding ISEE

# of Institutions

Shares Held

250K

Call Options Held

40K

Put Options Held

View Full List

About IVERIC bio, Inc.

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

More about ISEE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account